About Casper Pharma Private Limited
Data last updated:
Casper Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Suven Pharmaceuticals Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2016.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2016PTC423891. Its GSTIN is 36AAGCC3439C1ZY (Telangana). The company held 2 GST registrations, all of them active.
The company had an authorised share capital of ₹26.1 Cr and a paid-up capital of ₹26.08 Cr. It was led by directors including Sudhir Kumar Singh (Whole-Time Director) and Venkatanaga Kali Vetukuri Vara Prasada Raju.
Its last annual general meeting (AGM) was held on 01 August 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.43 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹8.34 Cr (net margin -27.4%) and EBITDA of -₹2.51 Cr (EBITDA margin -8.3%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years and 32% over five years.
The company had about 113 employees on its provident fund (EPFO) records before it was dissolved.
The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹104.27 Cr; the latest was in June 2022.
The last known website on record is cronuspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address215 Atrium C Wing 8th Floor 819 – 821, Andheri Kurla Road Chakala Andheri East, Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Casper Pharma Private Limited
The main business activities of Casper Pharma are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Casper Pharma Private Limited FY 2024 filings available
Casper Pharma Private Limited reported revenue of ₹30.43 Cr (up 151% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Casper Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 151% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Casper Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹30.43 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.51 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.34 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Casper Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -27.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Casper Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Casper Pharma Private Limited
Casper Pharma Private Limited is audited by K.Nagaraju and Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.Nagaraju and Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Casper Pharma Private Limited
Casper Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkatanaga Kali Vetukuri Vara Prasada Raju Also directs: Deccan Fine Chemicals (India) Private Limited | Director | 01 Dec 2023 | 2 Years 10 Months | As last reported |
| Sudhir Kumar Singh | Whole-Time Director | 01 Dec 2023 | 2 Years 10 Months | As last reported |
| Himanshu Agarwal Also directs: Sapala Organics Private Limited, Ipsp Solar Power Private Limited | Additional Director | 01 Aug 2024 | 2 Years 2 Months | As last reported |
Ownership and Shareholding of Casper Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Casper Pharma Private Limited
Casper Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Casper Pharma Private Limited
Casper Pharma Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹104.27 Cr; the latest was in June 2022.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2022 | Rights issue | ₹41.73 Cr | Investors: Suven Pharmaceuticals Limited |
| Mar 2017 | Funding round | ₹104.27 Cr | Investors: Casper Pharma Mauritius |
| Mar 2017 | Secondary share transfer | Undisclosed | Buyer: Casper Pharma Mauritius, Casper Pharma Mauritius & Mallemputi Ramakrishna Chowdary Seller: Casper Pharma LLC, Casper Pharma LLC & Mallemputi Ramakrishna Chowdury |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Casper Pharma Private Limited
Casper Pharma Private Limited has a workforce of 113 employees as of Mar 29, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Casper Pharma Private Limited
Casper Pharma has one previous CIN (Corporate Identification Number): U24233TG2016PTC102713. The current CIN is U24233MH2016PTC423891, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233MH2016PTC423891 | Current |
| U24233TG2016PTC102713 | Previous |
Recent Activity on Casper Pharma Private Limited
Casper Pharma Private Limited has 12 board changes on record since 2019: 3 appointments and 9 cessations. The latest: Himanshu Agarwal was appointed as Additional Director on 01 Aug 2024.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Casper Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Casper Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Casper Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Casper Pharma Private Limited
Casper Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCC3439C1ZY | Telangana | Active | 01 Jul 2017 |
| 36AAGCC3439C2ZX | Telangana | Active | 16 Mar 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Casper Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Casper Pharma Private Limited
Casper Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Casper Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2016 and is registered under CIN U24233MH2016PTC423891. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Casper Pharma was incorporated on 13 January 2016. It is registered with the Registrar of Companies, Mumbai.
Casper Pharma had 3 directors:
- Sudhir Kumar Singh - Whole-Time Director
- Venkatanaga Kali Vetukuri Vara Prasada Raju - Director
- Himanshu Agarwal - Additional Director
The CIN (Corporate Identification Number) of Casper Pharma is U24233MH2016PTC423891. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Casper Pharma is at 215 Atrium C Wing 8th Floor 819 – 821, Andheri Kurla Road Chakala Andheri East, Mumbai, Maharashtra, India – 400093.
Casper Pharma can be reached through the website cronuspharma.com. Its registered office is in Mumbai, Maharashtra, India.
Casper Pharma reported revenue of ₹30.43 Cr for FY 2024 (up 151% YoY).
Casper Pharma has an authorised share capital of ₹26.1 Cr and a paid-up capital of ₹26.08 Cr.
Casper Pharma reported a net loss of ₹8.34 Cr (net margin -27.4%) and EBITDA of -₹2.51 Cr (EBITDA margin -8.3%) for FY 2024, as per its filed financial statements.